dronabinol has been researched along with Nerve Pain in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (22.73) | 29.6817 |
| 2010's | 34 (51.52) | 24.3611 |
| 2020's | 17 (25.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Banday, J; Bano, N; Bhat, AQ; Dar, MJ; Dar, MS; Nalli, Y; Rafia, B; Rasool, JU; Sarkar, AR; Vishwakarma, RA | 1 |
| Essner, U; Mueller-Schwefe, GHH; Ueberall, MA; Vila Silván, C | 1 |
| Borrelli, F; Cinquini, M; Dwan, K; Filippini, G; Minozzi, S | 1 |
| Casey, SL; Mitchell, VA; Sokolaj, EE; Vaughan, CW; Winters, BL | 1 |
| Boursier, A; Charpentier, P; Dujardin, L; Ferret, L; Fulcrand, J; Gaboriau, L; Richet, E | 1 |
| Amin, S; Desai, D; Graziane, NM; Morris, DP; Raup-Konsavage, WM; Sepulveda, DE; Vrana, KE | 1 |
| Almdal, TP; Bach, FW; Enggaard, TP; Finnerup, NB; Hansen, CS; Heinesen, A; Holbech, JV; Jensen, TS; Petersen, M; Sindrup, SH; Vase, L; Zubcevic, K | 1 |
| Gobbi, G; Lopez-Canul, M; Pearl-Dowler, L; Posa, L; Teggin, A | 1 |
| Abraham, AD; Clark, JJ; Kruse, LC; Land, BB; Leung, EJY; Rivera, ZMG; Wong, BA | 1 |
| Haj, C; Linher-Melville, K; Mechoulam, R; Niazmand, MJ; Parzei, N; Shahid, A; Sharma, M; Sidhu, J; Singh, G; Zhu, KL; Zhu, YF | 1 |
| Dyck, JRB; Ferdaoussi, M; Maayah, ZH; Takahara, S | 1 |
| Cash, MC; Cunnane, K; Fan, C; Romero-Sandoval, EA | 1 |
| Baldasso, GM; Bicca, MA; Capasso, R; Dutra, RC; Gonçalves, ECD; Paes, RS | 1 |
| Fu, D; Gu, Q; Han, J; Li, Y; Liu, Y; Liu, Z; Qian, Z; Ren, W; Wu, Y | 1 |
| Bryk, M; Mlost, J; Starowicz, K | 1 |
| Dykukha, I; Essner, U; Malessa, R; Überall, MA | 1 |
| Casey, SL; Harley, J; Mitchell, VA; Vaughan, AC; Vaughan, CW; Winters, BL | 1 |
| Moser, U | 1 |
| King, KM; Myers, AM; Soroka-Monzo, AJ; Tallarida, RJ; Tuma, RF; Walker, EA; Ward, SJ | 1 |
| Atwal, N; Casey, SL; Vaughan, CW | 1 |
| Aviram, J; Samuelly-Leichtag, G | 1 |
| Abramov-Sommariva, D; Kugler, EM; Marziniak, M; Neubauer, C; Schimrigk, S; Werner, G | 1 |
| Lötsch, J; Tegeder, I; Weyer-Menkhoff, I | 1 |
| Häuser, W; Mücke, M; Petzke, F; Phillips, T; Radbruch, L | 1 |
| Brill, S; Dayan, L; Hendler, T; Jacob, G; Nahman-Averbuch, H; Sharon, H; Weizman, L | 1 |
| Atwal, N; Casey, SL; Mitchell, VA; Vaughan, CW | 1 |
| Carey, LM; Dhopeshwarkar, AS; Hohmann, AG; Li, AL; Lin, X; Liu, Y; Mackie, K; Makriyannis, A; Nikas, SP; Thomaz, AC | 1 |
| Chen, M; Han, J; Li, Y; Liu, Y; Liu, Z; Qian, Z; Ren, W; Wei, C; Wu, Y; Zhang, L; Zheng, Q | 1 |
| Gauter, B; Konrad, C; Rukwied, R | 1 |
| Brons, M | 1 |
| Klaschik, E; Nauck, F | 1 |
| Constantinescu, CS; Tanasescu, R | 1 |
| Cesar-Rittenberg, P; Hohmann, AG; Lynch, ME | 1 |
| Ehler, E; Hovorka, J; Lauder, H; Ratcliffe, S; Schofield, M; Serpell, M; Taylor, L | 1 |
| Almog, S; Eisenberg, E; Ogintz, M | 1 |
| Sedgwick, P | 1 |
| Ehler, E; Hoggart, B; Hovorka, J; Lauder, H; Lejčko, J; Ratcliffe, S; Serpell, M; Simpson, KH; Taylor, L | 1 |
| Doupe, M; Esfahani, F; Ethans, K; Galloway, K; Gomori, A; Namaka, M; Torabi, M; Turcotte, D | 1 |
| Garcia-Merino, A; Moreno Torres, I; Sanchez, AJ | 1 |
| Basinski, H; Jensen, HB; Stenager, E | 1 |
| Bazinski, H; Jensen, HB; Stenager, E | 1 |
| Leitl, MD; Negus, SS | 1 |
| Bramanti, P; Calabrò, RS; D'Aleo, G; Leo, A; Naro, A; Russo, M; Sessa, E | 1 |
| Bao, Q; Hu, N; Jiang, L; Xiao, D; Xie, J; Yu, L; Zhao, J | 1 |
| Baakman, AC; Beumer, TL; Cohen, A; Groeneveld, GJ; Heuberger, J; Kanhai, K; Killestein, J; Klaassen, E; Strijers, RLM; van Amerongen, G; van Gerven, J | 1 |
| Bennett, GJ; Collet, JP; Ducruet, T; Gamsa, A; Huynh, T; Robinson, A; Shapiro, S; Wang, T; Ware, MA | 1 |
| Bruel, BM; Fiess, RN; Holmes, SA; Rintala, DH; Tan, G | 1 |
| Anavi-Goffer, S; Baillie, G; Gertsch, J; Greig, IR; Irving, AJ; Pertwee, RG; Ross, RA | 1 |
| Ellis, RJ; Gouaux, B; Grant, I; Riggs, PK; Rossi, SS; Sorkin, LS; Vaida, F | 1 |
| Brower, V | 1 |
| Notcutt, WG | 1 |
| Bestard, J; Brady, S; Chan, C; Garven, A; Korngut, L; Liu, C; Mawani, S; Mehina, E; Toth, C | 1 |
| Langford, RM; Mares, J; Notcutt, W; Novakova, I; Novotna, A; Ratcliffe, S; Vachova, M | 1 |
| Deutsch, R; Donaghe, H; Gouaux, B; Marcotte, T; Sakai, S; Wilsey, B | 1 |
| Atlani, S; Attal, N; Brasseur, L; Clermont-Gnamien, S; Guirimand, F; Le Mercier, F | 1 |
| Russo, EB | 1 |
| Atlami, S; Attal, N; Bouhassira, D; Brasseur, L; Clermond-Gnamien, S; Guirimand, D | 1 |
| Batista, C; Berisha, M; Brenneisen, R; Karst, M; Salim, K; Schneider, U | 1 |
| Aslan, S; Mitchell, VA; Safaei, R; Vaughan, CW | 1 |
| Sibbald, B | 1 |
| Burstein, S | 1 |
| Karst, M | 1 |
| Haines, D; Hoggart, B; Morlion, BJ; Nurmikko, TJ; Serpell, MG; Toomey, PJ | 1 |
| Ernst, G; Kongsgaard, UE | 1 |
| Perez, J; Ribera, MV | 1 |
17 review(s) available for dronabinol and Nerve Pain
| Article | Year |
|---|---|
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Topics: Activities of Daily Living; Adolescent; Adult; Analgesics; Cannabinoids; Cannabis; Chronic Pain; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Plant Extracts; Quality of Life; Young Adult | 2022 |
The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation.
Topics: Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Inflammation; Neuralgia; Plant Extracts | 2020 |
Terpenoids, Cannabimimetic Ligands, beyond the
Topics: Alzheimer Disease; Anxiety; Bicyclic Monoterpenes; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cognitive Dysfunction; Dronabinol; Humans; Inflammatory Bowel Diseases; Neuralgia; Neuroprotective Agents; Nootropic Agents; Schizophrenia; Sesquiterpenes; Terpenes | 2020 |
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
Topics: Analgesics; Cannabidiol; Cannabinoids; Dronabinol; Humans; Hyperalgesia; Neuralgia; Pain Management | 2020 |
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Topics: Cannabidiol; Chronic Pain; Dronabinol; Drug Combinations; Humans; Neuralgia; Randomized Controlled Trials as Topic | 2021 |
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Cannabidiol; Cannabis; Chronic Pain; Dronabinol; Drug Combinations; Humans; Medical Marijuana; Neuralgia; Pain Management; Pain, Postoperative; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Topics: Analgesia; Analgesics; Animals; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dronabinol; Humans; Mice; Mice, Knockout; Neuralgia; Nociception; Pain Management; Receptor, Cannabinoid, CB1; Retrospective Studies | 2018 |
Cannabis-based medicines for chronic neuropathic pain in adults.
Topics: Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Cannabidiol; Chronic Pain; Codeine; Dronabinol; Humans; Medical Marijuana; Neuralgia; Numbers Needed To Treat; Randomized Controlled Trials as Topic | 2018 |
[Use and effectiveness of dronabinol (delta9-tetrahydrocannabinol) in chronic pain].
Topics: Analgesics, Non-Narcotic; Animals; Chronic Pain; Dronabinol; Drug Synergism; Humans; Mice; Narcotics; Neuralgia; Pain Measurement; Phytotherapy; Plant Extracts; Receptor, Cannabinoid, CB1; Signal Transduction; Synaptic Transmission; Treatment Outcome | 2004 |
[Dronabinol (delta9-tetrahydrocannabinol) in long-term treatment. Symptom control in patients with multiple sclerosis and spasticity, neuropathic pain, loss of appetite and cachexia].
Topics: Analgesics, Non-Narcotic; Anorexia; Cachexia; Dose-Response Relationship, Drug; Dronabinol; Long-Term Care; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Phytotherapy; Plant Extracts; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome | 2004 |
Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
Topics: Analgesics; Canada; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drug Evaluation, Preclinical; Humans; Multiple Sclerosis; Neuralgia; Plant Preparations; Randomized Controlled Trials as Topic | 2013 |
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Topics: Cannabidiol; Dronabinol; Drug Combinations; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Plant Extracts | 2014 |
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Treatment Outcome | 2014 |
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
Topics: Cannabidiol; Cannabinoids; Dronabinol; Drug Combinations; Evidence-Based Medicine; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Treatment Outcome | 2015 |
Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials.
Topics: Adult; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Arthritis, Experimental; Cannabinoids; Cell Line, Tumor; Clinical Trials, Phase II as Topic; Cytokines; Double-Blind Method; Dronabinol; Drug Evaluation, Preclinical; Edema; Female; Gastritis; Humans; Male; Mice; Middle Aged; Molecular Structure; Neuralgia; Randomized Controlled Trials as Topic; Rats | 2005 |
[Use of cannabinoids in palliative medicine].
Topics: Analgesics, Non-Narcotic; Antiemetics; Appetite; Cannabinoids; Dronabinol; Humans; Nausea; Neuralgia; Pain; Palliative Care; Pruritus; Receptors, Cannabinoid | 2008 |
Managing neuropathic pain with Sativex: a review of its pros and cons.
Topics: Analgesics; Cannabidiol; Chronic Disease; Clinical Trials as Topic; Dronabinol; Drug Combinations; Humans; Neuralgia; Pain Measurement; Plant Extracts | 2008 |
19 trial(s) available for dronabinol and Nerve Pain
| Article | Year |
|---|---|
Oral capsules of tetra-hydro-cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment.
Topics: Cannabidiol; Cannabinol; Dronabinol; Humans; Neuralgia | 2023 |
Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients.
Topics: Adult; Analgesics, Non-Narcotic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia | 2017 |
Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity.
Topics: Administration, Sublingual; Adult; Analgesics; Brain; Brain Mapping; Chronic Pain; Double-Blind Method; Dronabinol; Humans; Magnetic Resonance Imaging; Male; Medical Marijuana; Neural Pathways; Neuralgia; Pain Management; Rest | 2018 |
A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain.
Topics: Analgesics; Antineoplastic Agents; Cannabidiol; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Measurement; Pilot Projects; Treatment Outcome | 2014 |
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome | 2014 |
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
Topics: Adult; Aged; Chronic Pain; Dronabinol; Female; Humans; Male; Medical Marijuana; Metered Dose Inhalers; Middle Aged; Neuralgia; Pain Measurement; Treatment Outcome | 2014 |
A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
Topics: Adult; Aged; Analgesics; Cannabidiol; Diabetic Neuropathies; Dronabinol; Drug Combinations; Female; Follow-Up Studies; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Oral Sprays; Pain Management; Treatment Outcome | 2015 |
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Double-Blind Method; Dronabinol; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuralgia; Pain Measurement | 2015 |
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Topics: Adult; Brain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Laser-Evoked Potentials; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Management; Pain Measurement; Plant Extracts; Transcranial Magnetic Stimulation | 2016 |
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis.
Topics: Administration, Oral; Adult; Aged; Cognition; Cross-Over Studies; Dronabinol; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Muscle Spasticity; Neuralgia; Pain Measurement; Proof of Concept Study | 2018 |
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
Topics: Adult; Aged; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Linear Models; Male; Marijuana Smoking; Middle Aged; Neuralgia; Pain Measurement; Placebos; Quality of Life; Sleep; Treatment Outcome | 2010 |
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
Topics: Adult; Analgesics, Non-Narcotic; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pilot Projects; Spinal Cord Injuries; Treatment Outcome | 2010 |
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men.
Topics: Adult; Analgesics, Non-Narcotic; Appetite; Double-Blind Method; Dronabinol; Ghrelin; HIV Infections; Hormones; Humans; Leptin; Male; Middle Aged; Neuralgia; Peptide YY; Pilot Projects | 2012 |
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Chemotherapy, Adjuvant; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Placebo Effect; Treatment Outcome; Young Adult | 2012 |
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Topics: Administration, Mucosal; Administration, Oral; Adult; Analgesics, Non-Narcotic; Analysis of Variance; Cannabidiol; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Sclerosis; Neuralgia; Pain Measurement; Treatment Outcome | 2013 |
Low-dose vaporized cannabis significantly improves neuropathic pain.
Topics: Administration, Inhalation; Adult; Affect; Cannabis; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Hyperalgesia; Linear Models; Male; Middle Aged; Neuralgia; Neuropsychological Tests; Pain Measurement; Pain Threshold; Patient Selection; Phytotherapy; Socioeconomic Factors; Treatment Outcome; Volatilization | 2013 |
Are oral cannabinoids safe and effective in refractory neuropathic pain?
Topics: Administration, Oral; Adult; Aged; Analgesics, Non-Narcotic; Dose-Response Relationship, Drug; Dronabinol; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Pain, Intractable; Pilot Projects; Treatment Outcome | 2004 |
Determination of ajulemic acid and its glucuronide in human plasma by gas chromatography-mass spectrometry.
Topics: Adult; Aged; Dronabinol; Drug Stability; Female; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Male; Middle Aged; Neuralgia; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Analgesics; Cannabidiol; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Hyperesthesia; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Plant Extracts; Psychomotor Performance; Time Factors; Treatment Outcome | 2007 |
30 other study(ies) available for dronabinol and Nerve Pain
| Article | Year |
|---|---|
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
Topics: Animals; Cannabinoids; Cannabis; Cell Line, Tumor; Cell Proliferation; Humans; Neuralgia; Plant Leaves; Wnt Signaling Pathway | 2019 |
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
Topics: Adult; Analgesics; Analgesics, Opioid; Back Pain; Cannabidiol; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia; Registries; Retrospective Studies | 2022 |
Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Topics: Analgesics; Animals; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Disease Models, Animal; Dronabinol; Hallucinogens; Hyperalgesia; Mice; Neuralgia | 2022 |
[Use of dronabinol in the treatment of resistant neuropathic pain: Feedback from patients followed in a multidisciplinary pain center].
Topics: Dronabinol; Feedback; Humans; Neuralgia; Pain Clinics; Quality of Life; Retrospective Studies | 2023 |
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain.
Topics: Animals; Cannabinoids; Cannabis; Colorectal Neoplasms; Dronabinol; Mice; Neuralgia | 2022 |
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Dronabinol; Hyperalgesia; Male; Morphine; Neuralgia; Rats; Rats, Wistar | 2023 |
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoids; Dronabinol; Drug Tolerance; Female; Hyperalgesia; Male; Mice; Morphine; Neuralgia; Sciatic Nerve; Self Administration; Vocalization, Animal | 2020 |
An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain.
Topics: Animals; Cannabinoids; Dronabinol; Esters; Female; Male; Neuralgia; Quality of Life; Rats; Rats, Sprague-Dawley | 2020 |
Mapping cannabis potency in medical and recreational programs in the United States.
Topics: Analgesics; Cannabis; Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Illicit Drugs; Medical Marijuana; Neuralgia; United States | 2020 |
Activation of CB1 receptors on GABAergic interneurons in the ventrolateral orbital cortex induces analgesia.
Topics: Analgesia; Animals; Cannabinoid Receptor Agonists; Dronabinol; GABAergic Neurons; Interneurons; Male; Mice; Neuralgia; Pain Measurement; Prefrontal Cortex; Pyramidal Cells; Receptor, Cannabinoid, CB1 | 2020 |
Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Mice, Inbred C57BL; Neuralgia; Psychotropic Drugs; Sciatic Neuropathy; Treatment Outcome | 2021 |
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?
Topics: Cannabidiol; Dronabinol; Female; Humans; Middle Aged; Neuralgia; Quality of Life; Stroke | 2021 |
Single and combined effects of Δ
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Cannabidiol; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Vincristine | 2017 |
Cannabis constituent synergy in a mouse neuropathic pain model.
Topics: Analgesics; Animals; Cannabidiol; Cannabis; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia | 2017 |
THC and gabapentin interactions in a mouse neuropathic pain model.
Topics: Analgesics; Animals; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Gabapentin; Hyperalgesia; Male; Mice, Inbred C57BL; Motor Activity; Neuralgia; Sciatic Nerve; Time Factors; Touch | 2019 |
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
Topics: Analgesics, Opioid; Animals; Cannabinoids; Cell Line; Chromones; Dronabinol; Drug Tolerance; HEK293 Cells; Humans; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Neuralgia; Paclitaxel; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2019 |
Cannabinoids-induced peripheral analgesia depends on activation of BK channels.
Topics: Analgesia; Animals; Cannabinoids; Dronabinol; Endocannabinoids; Large-Conductance Calcium-Activated Potassium Channels; Male; Mice; Mice, Inbred C57BL; Neuralgia; Pain Management; Receptor, Cannabinoid, CB1 | 2019 |
[Dronabinol therapy in diabetic polyneuropathy and diabetic osteoarthropathy].
Topics: Analgesics, Non-Narcotic; Bone Diseases; Chronic Pain; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Dronabinol; Drug Substitution; Drug Therapy, Combination; Female; Humans; Joint Diseases; Middle Aged; Narcotics; Neuralgia; Pain Measurement; Phytotherapy; Plant Extracts; Quality of Life | 2004 |
What is a crossover trial?
Topics: Cannabinoid Receptor Agonists; Cross-Over Studies; Dronabinol; Humans; Multiple Sclerosis; Neuralgia; Randomized Controlled Trials as Topic; Research Design | 2014 |
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
Topics: Analgesics; Analgesics, Opioid; Animals; Bupropion; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Formaldehyde; Hyperalgesia; Ketoprofen; Male; Medial Forebrain Bundle; Morphine; Neuralgia; Rats; Rats, Sprague-Dawley; Self Stimulation | 2016 |
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cell Line; Dronabinol; Drug Carriers; Drug Delivery Systems; Hyperalgesia; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Nanoparticles; Neuralgia; Oligopeptides; Oxidation-Reduction; Pain Management; Silicon Dioxide | 2016 |
Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
Topics: Administration, Oral; Administration, Sublingual; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Smoking; Meta-Analysis as Topic; Multiple Sclerosis; Neuralgia; Pain; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic | 2009 |
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Topics: Allosteric Regulation; Analgesics; Cannabinoids; Cannabis; Dronabinol; HEK293 Cells; Humans; Ligands; Lysophospholipids; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuralgia; Phosphoproteins; Phosphorylation; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Rimonabant | 2012 |
New pain drugs in pipeline, but challenges to usage remain.
Topics: Analgesics; Analgesics, Opioid; Antineoplastic Agents; Cannabidiol; Cannabinoids; Clinical Trials as Topic; Dronabinol; Drug Combinations; Drugs, Investigational; Humans; Neoplasms; Neuralgia; Pain; Palliative Care; Plant Extracts | 2012 |
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Cannabidiol; Caregivers; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Off-Label Use; Phytotherapy; Plant Extracts; Practice Patterns, Physicians'; Sleep; Surveys and Questionnaires; United Kingdom | 2013 |
[The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Anxiety; Data Interpretation, Statistical; Depression; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Pilot Projects; Polyneuropathies; Quality of Life; Surveys and Questionnaires | 2002 |
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Topics: Administration, Oral; Affect; Appetite; Cannabidiol; Cannabinoids; Cannabis; Clinical Trials, Phase III as Topic; Double-Blind Method; Dronabinol; Humans; Multiple Sclerosis; Muscle Spasticity; Neuralgia; Plant Extracts; Reflex, Abnormal; Safety; Sleep; Switzerland; Treatment Outcome; United Kingdom | 2003 |
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dronabinol; Excitatory Amino Acid Antagonists; Inflammation; Ligation; Male; Motor Activity; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2005 |
Conditional okay for cannabis prescription drug.
Topics: Canada; Cannabidiol; Cannabis; Dronabinol; Drug Approval; Drug Combinations; Humans; Multiple Sclerosis; Neuralgia; Phytotherapy; Plant Extracts | 2005 |
Comments on "cannabimimetic properties of ajulemic acid".
Topics: Analgesics; Animals; Clinical Trials as Topic; Dronabinol; Humans; Neuralgia | 2007 |